KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Current Leases (2019 - 2025)

Biolife Solutions (BLFS) has disclosed Current Leases for 7 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Leases rose 53.74% to $2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 53.74% increase, with the full-year FY2025 number at $2.2 million, up 53.74% from a year prior.
  • Current Leases was $2.2 million for Q4 2025 at Biolife Solutions, up from $2.2 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $2.9 million in Q1 2023 to a low of $146000.0 in Q3 2021.
  • A 5-year average of $1.5 million and a median of $1.6 million in 2024 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: skyrocketed 34375.0% in 2021, then tumbled 89.62% in 2022.
  • Biolife Solutions' Current Leases stood at $2.8 million in 2021, then grew by 3.7% to $2.9 million in 2022, then tumbled by 55.03% to $1.3 million in 2023, then increased by 13.45% to $1.5 million in 2024, then skyrocketed by 53.74% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Current Leases are $2.2 million (Q4 2025), $2.2 million (Q3 2025), and $2.2 million (Q2 2025).